CRISPR Therapeutics AGCRSPNASDAQ
Loading
Net other income and expenses outside core operations
Percentile
P0
Near historical low
vs 5Y Ago
-1.5x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-9.65M | -109.3% |
| 2024 | $103.90M | +44.7% |
| 2023 | $71.82M | +216.9% |
| 2022 | $22.66M | +277.5% |
| 2021 | $6.00M | -5.9% |
| 2020 | $6.38M | -69.0% |
| 2019 | $20.57M | +474.9% |
| 2018 | $-5.49M | -179.8% |
| 2017 | $-1.96M | -104.3% |
| 2016 | $45.41M | - |